Technology
Health
Medical

Inogen

$90.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.56 (-4.82%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Inogen and other stocks, options, ETFs, and crypto commission-free!

About

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. Read More The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Employees
1,099
Headquarters
Goleta, California
Founded
2001
Market Cap
1.96B
Price-Earnings Ratio
39.15
Dividend Yield
0.00
Average Volume
390.62K
High Today
$94.57
Low Today
$89.79
Open Price
$94.17
Volume
181.51K
52 Week High
$287.79
52 Week Low
$89.79

Collections

Technology
Health
Medical
Advertising and Marketing
Therapy
Business Services
2014 IPO
US

News

TradingNewsNowMar 22

Up or Down: Inogen Inc (NASDAQ: INGN)

Inogen Inc trades as part of the medical devices industry and trades as part of the healthcare sector. The company CEO is Scott Wilkinson. Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Previous Intraday Trading Performance: The INGN stock showed a previous change of 1.51% with an open at 93.08 and a close of 94.68. It reached an...

192
PR NewswireMar 21

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Inogen, Inc.; Investors with Losses in Excess of $100K are Encouraged to Contact the Firm - INGN

NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Inogen, Inc.

0
Associated PressMar 19

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Inogen, Inc. Investors

This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. LOS ANGELES--(BUSINESS WIRE)--Mar 19, 2019--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Inogen, Inc. investors (“Inogen” or the “Company”) (NASDAQ: INGN ) concerning the Company and its officers’ ...

66

Earnings

$0.23
$0.40
$0.56
$0.73
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 29, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.